TAKE THIS POLL |
|
|
- Winning Product Launch Strategies - Maximizing sales from new pharmaceutical products - New Research Report 4 Jul 2008 19:56 GMT
... new drug launches along with key factors for successful launches. Case studies include: • Eli Lilly: Alimta (pemetrexed) • Bristol-Myers Squibb: Reyataz (arazanavir) • Genentech/Roche: Avastin (bevacizumab) Use this report ...
- Eli Lilly fined $60,000 over Cialis spin 4 Jul 2008 15:11 GMT
... self-regulating complaints body found breached the ban on promoting drugs direct to the public. Eli Lilly, the maker of the erectile dysfunction drug Cialis, was also found by Medicines Australia's ...
- SAS in Leaders quadrant for customer data mining applications 4 Jul 2008 10:57 GMT
... companies globally – including American Honda Motor Co., Daimler Chrysler, The Dow Chemical Co., Eli Lilly and Company¸ Hartford Life, Healthways, RCI Global Vacation Network, Telstra AP, Verizon Wireless, and ...
- FEATURE-Siberian jail is champion in fight against TB 4 Jul 2008 10:35 GMT
... has also been funded by the Bill & Melinda Gates Foundation and pharmaceutical group Eli Lilly, and in 2004 received a grant worth $10.8 million over five years from the ...
- Eli Lilly urged to settle over Zyprexa 4 Jul 2008 07:29 GMT
... Eli Lilly urged to settle over Zyprexa Judge wants drug maker to come to terms in ...
- Siberian jail is champion in fight against TB 4 Jul 2008 06:32 GMT
... has also been funded by the Bill & Melinda Gates Foundation and pharmaceutical group Eli Lilly, and in 2004 received a grant worth $10.8 million over five years from the ...
- More tests urged for new drugs for diabetes 4 Jul 2008 04:34 GMT
... year, according to pharmaceutical research firm IMS Heath. Takeda Pharmaceuticals' Actos, GlaxoSmithKline's Avandia, and Eli Lilly and Amylin Pharmaceutical's Byetta dominate the U.S. market. Nearly 24 million Americans have Type ...
- FDA Panel Urges More Testing for Diabetes Drugs 4 Jul 2008 04:28 GMT
... year, according to pharmaceutical research firm IMS Heath. Takeda Pharmaceuticals' Actos, GlaxoSmithKline's Avandia, and Eli Lilly and Amylin Pharmaceutical's Byetta currently dominate the U.S. market. Nearly 24 million Americans have ...
- FDA Panel Urges More Testing for Diabetes Drugs - July 03, 2008 4 Jul 2008 04:27 GMT
... year, according to pharmaceutical research firm IMS Heath. Takeda Pharmaceuticals' Actos, GlaxoSmithKline's Avandia, and Eli Lilly and Amylin Pharmaceutical's Byetta currently dominate the U.S. market. Nearly 24 million Americans have ...
- require longer studies 4 Jul 2008 04:26 GMT
... year, according to pharmaceutical research firm IMS Heath. Takeda Pharmaceuticals' Actos, GlaxoSmithKline's Avandia, and Eli Lilly and Amylin Pharmaceutical's Byetta currently dominate the U.S. market. Nearly 24 million Americans have ...
- Judge urges Eli Lilly to settle multibillion fraud lawsuit over top-selling drug Zyprexa 4 Jul 2008 03:59 GMT
... Judge urges Eli Lilly to settle multibillion fraud lawsuit over top-selling drug Zyprexa The Associated Press - Friday, ...
- Judge urges Eli Lilly to settle multibillion fraud lawsuit over top - selling drug Zyprexa 4 Jul 2008 03:36 GMT
... "A global settlement for the overpricing claims and any other claims is desirable," he wrote. "Legal ...
- Judge urges Eli Lilly to settle Zyprexa lawsuit 4 Jul 2008 03:33 GMT
... ...
- Judge urges Eli Lilly to settle Zyprexa lawsuit 4 Jul 2008 03:09 GMT
... ...
- Siberian jail is champion in fight against TB 4 Jul 2008 01:31 GMT
... has also been funded by the Bill & Melinda Gates Foundation and pharmaceutical group Eli Lilly, and in 2004 received a grant worth $10.8 million over five years from the ...
- Alzheimer's drug fails final test 4 Jul 2008 00:55 GMT
... daily activities. The failure also casts doubt on several other plaque-inhibiting drugs under development. Eli Lilly is in the late-stage testing of a drug that works similarly to Flurizan, by ...
- Bio-Pharma Launch Value Maximized Through New Product Commercialization Excellence 3 Jul 2008 20:22 GMT
... Excellence. The benchmarking study included such influential companies as Abbott, Allergan, Amgen, AstraZeneca, Bayer, Eli Lilly, Genentech, GSK, Merck and Novartis. Key benchmark metrics and executive insights provide a basis ...
- Pfizer Eliminating Some-Not All-Financial Support for Physician Courses 3 Jul 2008 19:25 GMT
... Pfizer began disclosing details of its educational grants on its Web site in May. Eli Lilly and Company began making similar disclosures last year. Doctors need to attend these courses ...
- Healthcare group spent $260K lobbying in 1Q 3 Jul 2008 18:29 GMT
... to reform Medicare, protect patients' genetic information and improve health information technology. Drug makers Eli Lilly & Co. and Pfizer Inc., as well as drug distributor AmerisourceBergen Corp., are among ...
- Eli Lilly most esteemed pharma company for psychiatrists: Verispan 3 Jul 2008 17:20 GMT
... Psychiatrists cited Eli Lilly as the top pharmaceutical company in overall “esteem,” according to a new Verispan study. ...
- Children's suicide attempts raise concerns about ADHD medication 3 Jul 2008 16:52 GMT
... a particular drug so they can look for any warning signs, Mr. Cassels said. Eli Lilly Canada, which makes Strattera, declined to provide a spokesperson to respond to questions yesterday. ...
- FDA Panel recommends Exhaustive Tests for new Diabetes Drugs 3 Jul 2008 16:33 GMT
... than what we already have.” Several drugmakers, including Glaxo, Bristol-Myers Squibb Co, AstraZeneca Plc, Eli Lilly and Co and Amylin Pharmaceutical Co, are working to bring new diabetes drugs to ...
- Sector Snap: Diabetes drug developers 3 Jul 2008 16:11 GMT
... cents, or 3.9 percent, to $24.52 in midday trading. The company and Indianapolis-based partner Eli Lilly & Co. make Byetta, a twice-daily treatment. At issue for them is the development ...
- FDA: Diabetes Drugs Should Face Tougher Standards 3 Jul 2008 15:30 GMT
... year, according to pharmaceutical research firm IMS Heath. Takeda Pharmaceuticals' Actos, GlaxoSmithKline's Avandia, and Eli Lilly and Amylin Pharmaceutical's Byetta currently dominate the U.S. market. Nearly 24 million Americans have ...
- Panel urges stricter diabetes drug testing 3 Jul 2008 14:59 GMT
... year, according to pharmaceutical research firm IMS Heath. Takeda Pharmaceuticals' Actos, GlaxoSmithKline's Avandia, and Eli Lilly and Amylin Pharmaceutical's Byetta currently dominate the U.S. market. Nearly 24 million Americans have ...
1 - 25 of 313 next >
News by PR Newswire
|
